SAGE

Therapeutic Advances in Drug Safety Template

Write in a clean editor, then format for Therapeutic Advances in Drug Safety in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Therapeutic Advances in Drug Safety format

Therapeutic Advances in Drug Safety is a peer-reviewed journal published by SAGE, covering Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical Practices and Patient Outcomes, Patient Safety and Medication Errors.

PublisherSAGE
Reference styleAuthor–year (Harvard)
Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Drug Safety, 12(3), pp. 45–58.

Formats any DOI in Therapeutic Advances in Drug Safety style. No sign-up.

Publishes research inPharmacovigilance and Adverse Drug Reactions Pharmaceutical Practices and Patient Outcomes Patient Safety and Medication Errors Medication Adherence and Compliance Pharmaceutical studies and practices
ISSN2042-0986
Citation impact (2-yr)3.36
h-index64
i10-index304
Total citations18,046
Article processing charge$2,200
Open accessYes
Top institutions publishing hereUniversity of Aberdeen
Journal websiteus.sagepub.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Therapeutic Advances in Drug Safety per year

20
2014
29
2015
32
2016
35
2017
51
2018
52
2019
35
2020
38
2021
35
2022
28
2023
51
2024
68
2025

Citation impact of Therapeutic Advances in Drug Safety by publication year

3.7K
2014
1.3K
2015
1.1K
2016
1.6K
2017
1.8K
2018
1.3K
2019
1.3K
2020
678
2021
626
2022
261
2023
294
2024
204
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Therapeutic Advances in Drug Safety

Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem

Carl Llor, Lars Bjerrum · 16 Oct 2014

Antimicrobial resistance is a global public health challenge, which has accelerated by the overuse of antibiotics worldwide. Increased antimicrobial resistance is the cause of severe infections, complications, longer hospital stays and increased mortality. Overprescribing of antibiotics is associated with an increased risk of adverse effects, more frequent re-attendance and increased medicalization of self-limiting conditions. Antibiotic…

2,096 citations Cite SaveGo to paper →
Predicting risk of adverse drug reactions in older adults

Amanda Lavan, Paul Gallagher · 16 Nov 2015

Adverse drug reactions (ADRs) are common in older adults, with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding being amongst the most common clinical manifestations. ADR risk increases with age-related changes in pharmacokinetics and pharmacodynamics, increasing burden of comorbidity, polypharmacy, inappropriate prescribing and suboptimal monitoring of drugs. ADRs are a preventable cause of…

An overview of prevalence, determinants and health outcomes of polypharmacy

Mina Khezrian, Christopher J. McNeil, Alison D. Murray et al. · 1 Jan 2020

A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are likely to be on a polypharmacy regime, is limited. This is a narrative literature review that aims…

Naloxone dosage for opioid reversal: current evidence and clinical implications

Rachael Rzasa Lynn, Jeffrey L. Galinkin · 13 Dec 2017

Opioid-related mortality is a growing problem in the United States, and in 2015 there were over 33,000 opioid-related deaths. To combat this mortality trend, naloxone is increasingly being utilized in a pre-hospital setting by emergency personnel and prescribed to laypersons for out-of-hospital administration. With increased utilization of naloxone there has been a subsequent reduction in…

Drug-induced QT interval prolongation: mechanisms and clinical management

Senthil Nachimuthu, Manish D. Assar, Jeffrey Schussler · 26 Jul 2012

The prolonged QT interval is both widely seen and associated with the potentially deadly rhythm, Torsades de Pointes (TdP). While it can occur spontaneously in the congenital form, there is a wide array of drugs that have been implicated in the prolongation of the QT interval. Some of these drugs have either been restricted or…

Therapeutic Advances in Drug Safety template — frequently asked questions

How do I write a paper in the Therapeutic Advances in Drug Safety format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Therapeutic Advances in Drug Safety template. When you export, DocuGuru compiles the paper into the official SAGE format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Therapeutic Advances in Drug Safety use?
Therapeutic Advances in Drug Safety uses Author–year (Harvard) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Drug Safety, 12(3), pp. 45–58.
Do I need to know LaTeX to submit to Therapeutic Advances in Drug Safety?
No. DocuGuru generates the sagej LaTeX class and compiles the PDF for you in the background, so you get a SAGE-ready Therapeutic Advances in Drug Safety document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Therapeutic Advances in Drug Safety template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Therapeutic Advances in Drug Safety format with correct headings, figures, tables, and author–year citations.
Who publishes Therapeutic Advances in Drug Safety?
Therapeutic Advances in Drug Safety is a multidisciplinary journal published by SAGE. DocuGuru's Therapeutic Advances in Drug Safety template matches SAGE's official submission format.
Can I export a submission-ready Therapeutic Advances in Drug Safety PDF?
Yes — DocuGuru produces a PDF built with the official Therapeutic Advances in Drug Safety template (the sagej class) that is ready to submit to SAGE, together with the matching LaTeX source files.
How much does the Therapeutic Advances in Drug Safety template cost?
You can start writing in the Therapeutic Advances in Drug Safety template for free. Exporting the final submission-ready Therapeutic Advances in Drug Safety PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Therapeutic Advances in Drug Safety template